Amy S.F. Lutz is a historian of medicine at the University of Pennsylvania in Philadelphia, vice president of the National Council on Severe Autism and the parent of a profoundly autistic son, Jonah, 24. She has written about profound autism for many platforms, including The Atlantic, Psychology Today, Spectrum and Slate. Her most recent book is “Chasing the Intact Mind: How the Severely Autistic and Intellectually Disabled Were Excluded From the Debates That Affect Them Most” (2023). She is also the author of “We Walk: Life With Severe Autism” (2020) and “Each Day I Like It Better: Autism, ECT, and the Treatment of Our Most Impaired Children” (2014). She lives outside of Philadelphia with her husband and whichever of her five children happen to be home at the time.
Amy S.F. Lutz
Writer
From this contributor
Building bridges: Collaboration across the autism community
An autistic person and the mother of an autistic child explore partnership in the autism community.
Building bridges: Collaboration across the autism community
Adults with disabilities deserve right to choose where to live
The idea that one residential model is appropriate for the entire spectrum of intellectual and developmental disability is patently absurd.
Adults with disabilities deserve right to choose where to live
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.